Safety study of GB18 injection in healthy adults
This early-phase trial tests a new injection called GB18 in healthy adults to see if it is safe and how the body processes it. It may help researchers understand how to treat conditions that involve the immune system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are generally healthy (no serious medical conditions).
- Your body mass index (BMI) is between 18.5 and 26.
- You are not pregnant, nursing, or planning to become pregnant, and will use birth control for 6 months after the study.
- You have not had a live vaccine in the last 28 days, and no recent drug or alcohol misuse.
- You are willing to avoid smoking, certain medications, and blood donation during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests a new drug called GB18 to help cancer patients who have experienced significant weight loss and muscle wasting—a condition called cancer cachexia. The drug works by targeting a specific protein involved in weight loss, and researchers want to learn if it can help patients regain weight and strength while also being safe.
This study tests a new injection called GenSci164 in healthy adults. It helps find out how the drug works in the body and if it is safe. Participants receive the injection and are monitored for effects.
This is an early-stage safety study testing a new injectable medication (GenSci155) that affects growth and metabolism. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in patients with medical conditions.
This is an early-stage safety test of a new injectable drug (SSS68) in healthy volunteers with no serious medical conditions. Researchers will give one dose under the skin and monitor how your body tolerates it over time.
This trial tests a new medicine, BW-50218, in healthy volunteers to see how safe it is and how the body processes it. If you are generally healthy and meet the specific requirements below, you may be able to help with early research on this potential treatment.
This is an early-stage (Phase 1) safety test of a new investigational drug called BW-20805-2-1001 in people without serious health conditions. Researchers want to understand how the drug is tolerated and processed by the body when given as an injection.
Hear when a new Cancer Cachexia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.